IRTC Q4 2023 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$133M+17.7% YoY

Gross Profit

$87M66.0% margin

Operating Income

-$39M-29.6% margin

Net Income

-$39M-29.2% margin

EPS (Diluted)

$-1.26

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$29M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$433M

Total Liabilities

$223M

Stockholders' Equity

$210M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$133M	$113M	+17.7%
Gross Profit	$87M	$79M	+11.1%
Operating Income	-$39M	-$21M	-89.3%
Net Income	-$39M	-$20M	-91.6%

Revenue Segments

Commercial Payors

$71M57%

Centers For Medicare And Medicaid

$34M28%

Healthcare Institutions

$19M15%